Therachon takes in $60 mln

Basel, Switzerland-based Therachon, a biotechnology company focused on rare diseases, has closed $60 million in financing. Novo Holdings led the round with participation from Cowen Healthcare Investments, Pfizer Ventures, Tekla Capital Management LLC, Versant Ventures, OrbiMed, Bpifrance and Inserm Transfert Initiative.

Source: Press Release